Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 409

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 409
---
 secure digital platform for accessing test results and scheduling, in certain circumstances, consultations, complemented by tailored health plans aimed at prevention and wellness. In early 2025, Rewell transitioned from a direct -to-consumermodel to a business -to-business-to-consumerstrategy, leveraging partnerships with diagnostic laboratories and wellness professionals to improve scalability and economic sustainability across Latin America. This shift is aligned with OmnigenicsAI’s broader strategy to scale through a consortium -basedmodel involving local laboratory partners. Pursuant to a contribution agreement between the Parent and us, on February 26, 2024, all of the issued and outstanding shares of Heritas Argentina were contributed to us, resulting in Heritas Argentina becoming our wholly owned subsidiary (the “Heritas Contribution”). In exchange for the Heritas Contribution, we issued 30 million shares to the Parent. This restructuring was completed with a view to prepare us for our strategic business combination with APx. Key Factors Affecting Operating Results The Company has historically incurred significant losses: $1,322,306, $4,516,095 and $1,291,932 for the six months ended December31, 2024, and for the fiscal years ended June 30, 2024 and 2023, respectively. The Company has also recorded accumulated deficits of $8,263,789, $6,941,483 and $3,588,427 as of December31, 2024, June 30, 2024 and 2023, respectively. Additionally, the Company’s recurring cash outflows from operations amounted to $816,433, $1,885,895 and $1,306,705 for the six months ended December31, 2024 and for the years ended June 30, 2024 and 2023, respectively. We expect to continue to incur significant expenses and operating losses for the foreseeable future as we continue to expand research and development efforts, enhance our existing consumer products, services and business model, broaden our customer base, work with regulatory agencies, and hire additional employees to support our growth. Any future losses may have an adverse effect on our shareholders’ equity and working capital, which could negatively 208 impact our operations and investments capacity. A failure to sustain or grow its revenue levels or obtain sufficient profitability levels may negatively affect our business, financial condition, results of operations and cash flows. In this context, we may need to raise additional capital in the future through share issuances, which could cause the market price of our shares